- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
10 Cancer Researchers Can Receive $7.5 Million in Funds
Stand Up 2 Cancer, in collaboration with the American Association for Clinical Research, will be funding innovative research grants with a potential to further translational cancer research.
Stand Up to Cancer (SU2C), in collaboration with the American Association for Cancer Research, has announced funds to the tune of $7.5 million made available to inovative work in the field of cancer research. This amount will be evenly distributed between 10 scientists as an Innovative research Grant (IRG) over a period of 10 years.
"IRGs offer financial support to independent, early-career scientists pursuing novel, high-risk, high-reward cancer research proposals that have significant potential for translation to clinical application and hold great promise for advancing SU2C’s overarching goal of improving and saving lives," says the associated press release.
The deadline for applicant's letter of intent is November 13, 2015.
Read more at http://bit.ly/1QlAZYz.
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More
Real-World Evidence Confirms the Benefits of JAK Inhibitors in Patients With Rheumatoid Arthritis
January 16th 2025This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in improving treatment adherence, persistence, clinical outcomes, and patient-reported outcomes among US patients with rheumatoid arthritis.
Read More
